SCHEMBL175406

SCHEMBL175406

O=C1CCCNN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2794651 0.92
SCHEMBL540663 0.89
Fluoride SCHEMBL29583107 0.89
SCHEMBL28066549 0.86 OR51E2 (0.41)
SCHEMBL3360735 0.83
SCHEMBL27864158 0.83 CRBN (0.36)
SCHEMBL169833 0.81
Hydrochloric Acid SCHEMBL3405773 0.79
SCHEMBL11414395 0.79
Phosphine SCHEMBL27974343 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367099-A1 PYRIDINONE MK2 INHIBITORS AND USES THEREOF Xinthera, Inc. (US) 2024-05-15 EP claimed
CN-117651698-A Pyridone MK2 inhibitors and uses thereof 新特拉有限公司 2024-03-05 CN claimed
CN-114057650-B Method for preparing 4, 5-dihydropyridazin-3-one compounds by one-pot method 温州大学 2023-03-28 CN claimed
WO-2023283338-A1 PYRIDINONE MK2 INHIBITORS AND USES THEREOF XINTHERA, INC. (US) 2023-01-12 WO claimed
CN-114057650-A Method for preparing 4, 5-dihydropyridazin-3-one compounds by one-pot method 温州大学 2022-02-18 CN claimed
US-20130172323-A1 PYRIDAZINONES AS GPR119 AGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-07-04 US claimed
US-20090104116-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2009-04-23 US claimed
EP-2049503-A1 QUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES AS P38 KINASE INHIBITORS Amgen Inc. (US) 2009-04-22 EP claimed
EP-1979342-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF Jerini AG (DE) 2008-10-15 EP claimed
US-20080032973-A1 2-Quinazolinone compounds and methods of use AMGEN INC. (US) 2008-02-07 US claimed
US-20050239808-A1 Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur TRANSMIT GESELLSCHAFT FUR TECHNOLOGIETRANSFER MBH (DE) 2005-10-27 US claimed
WO-2005070460-A2 COMBINATION THERAPY WITH 5-HT1A AND 5-HT1B RECEPTOR ANTAGONISTS RECORDATI IRELAND LIMITED (IE) 2005-08-04 WO claimed
EP-1503990-A1 ACTIVE SUBSTANCES FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF DISEASES IN WHICH ABNORMAL PROTEIN STRUCTURES OCCUR Transmit Gesellschaft für Technologietransfer mbH (DE) 2005-02-09 EP claimed
WO-2003095429-A1 ACTIVE SUBSTANCES FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF DISEASES IN WHICH ABNORMAL PROTEIN STRUCTURES OCCUR TransMIT Gesellschaft für Technologietransfer mbH (DE) 2003-11-20 WO claimed
EP-0468924-A2 New herbicides CIBA-GEIGY AG (CH) 1992-01-29 EP claimed
EP-0193013-B1 BENZIMIDAZOLYL-PYRIDAZINONES MERCK PATENT GmbH (DE) 1989-04-19 EP claimed
EP-0272914-A2 6-Benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones ORTHO PHARMACEUTICAL CORPORATION (US) 1988-06-29 EP claimed
EP-0193013-A2 Benzimidazolyl-pyridazinones MERCK PATENT GmbH (DE) 1986-09-03 EP claimed
EP-0129791-A2 Tetrahydropyridazinone derivatives, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1985-01-02 EP claimed
EP-0010156-A1 6-Arylpyridazine-3-ones, pharmaceutical compositions containing them and process for their preparation MERCK PATENT GmbH (DE) 1980-04-30 EP claimed